Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03966170

Citicoline as Neuroprotector in Preterm

Citicoline as neuroprotector in preterm

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pre-Term Female Urogenital Diseases and Pregnancy Complications Obstetric Labor Complications Obstetric Labor, Premature Pregnancy Complications Premature Birth Urogenital Diseases

Age range

Up to 1 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Sherief Abd-Elsalam

Tanta, Egypt

Location status: Recruiting

Location contact

Sherief Abd-Elsalam

CONTACT

About this study

Efficacy of Citicoline as neuroprotector in preterm; A randomized controlled trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Preterm on CPAP or ventilator

Exclusion criteria

  • Multiple congenital anomalies

Treatment and study plan

Citicoline

Drug

Citicoline as neuroprotector

Placebo oral tablet

Drug

placebo drug

Primary outcomes

  1. Number of children with affection of the brain

    Time frame: 6 months

    Number of children with affection of the brain

Study contacts

Contact information is provided by the study sponsor or research team.

Sherief Abd-Elsalam, ass. prof.

CONTACT

[email protected]

00201147773440

Sponsors and collaborators

Lead sponsor

Sherief Abd-Elsalam

Other

Registry information

Official study title

Efficacy of Citicoline as Neuroprotector in Preterm; A Randomized Controlled Trial

Important dates

Study start
2019
Primary completion
2028
Study completion
2028
First posted
May 29, 2019
Registry last updated
May 29, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.